Related Experiment Video
Updated: Dec 4, 2025
Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
Are Patients with Asthma and Chronic Obstructive Pulmonary Disease Preferred Targets of COVID-19?
Belaid Bouazza1, Dihia Hadj-Said1, Karen A Pescatore2
1Department of Biochemistry and Microbiology, Faculty of Biological and Agricultural Sciences, Mouloud Mammeri University, Tizi-Ouzou, Algeria.
Insights
The impact of COVID-19 on asthma and COPD patients is reviewed, exploring potential risk factors and management strategies. Further research is needed to understand the interaction between these conditions and SARS-CoV-2.
Area of Science:
- Pulmonology
- Infectious Diseases
- Epidemiology
Background:
- The COVID-19 pandemic, caused by SARS-CoV-2, has led to millions of infections and deaths globally.
- The role of chronic respiratory diseases like asthma and COPD as COVID-19 risk factors is debated, with conflicting data from different regions.
- Underlying mechanisms for potential interactions between COVID-19 and chronic respiratory conditions are not yet fully understood.
Purpose of the Study:
- To review the impact of COVID-19 on patients with asthma and COPD.
- To discuss potential risk factors and treatment options for these patients during the pandemic.
- To explore patient management strategies in the context of COVID-19.
Main Methods:
- This is a review article, synthesizing existing research and observations.
- The review examines physiological changes, immune responses, and medication effects in patients with chronic respiratory diseases.
- It analyzes epidemiological data and clinical observations regarding COVID-19 in asthma and COPD populations.
Main Results:
- Prevalence of chronic respiratory conditions in COVID-19 patients varies geographically, with higher rates reported in the US and Europe compared to China.
- Physiological changes, immune responses, and treatments (e.g., corticosteroids) may uniquely affect individuals with pre-existing respiratory conditions.
- The review highlights the need for tailored management approaches for asthma and COPD patients during the pandemic.
Conclusions:
- COVID-19 presents unique challenges for individuals with asthma and COPD due to underlying inflammation and potential treatment interactions.
- Further research is crucial to elucidate the complex interplay between SARS-CoV-2 infection and chronic respiratory diseases.
- Effective patient management strategies are essential to mitigate the impact of COVID-19 on this vulnerable population.
Abstract:
The coronavirus pandemic, known as coronavirus disease 2019 (COVID-19), is an infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus first identified in patients from Wuhan, China. Since December 2019, SARS-CoV-2 has spread swiftly around the world, infected more than 25 million people, and caused more than 800,000 deaths in 188 countries. Chronic respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD) appear to be risk factors for COVID-19, however, their prevalence remains controversial. In fact, studies in China reported lower rates of chronic respiratory conditions in patients with COVID-19 than in the general population, while the trend is reversed in the United States and Europe. Although the underlying molecular mechanisms of a possible interaction between COVID-19 and chronic respiratory diseases remain unknown, some observations can help to elucidate them. Indeed, physiological changes, immune response, or medications used against SARS-CoV-2 may have a greater impact on patients with chronic respiratory conditions already debilitated by chronic inflammation, dyspnea, and the use of immunosuppressant drugs like corticosteroids. In this review, we discuss importance and the impact of COVID-19 on asthma and COPD patients, the possible available treatments, and patient management during the pandemic.
Related Concept Videos
01:26COPD: Management Using Bronchodilators and Corticosteroids
01:22Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:29Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
01:29Asthma-I: Introduction